NLTX NASDAQ
Neoleukin Therapeutics, Inc.
1W: +5.8%
1M: +4.2%
3M: -5.9%
1Y: +60.1%
3Y: -94.4%
5Y: -69.8%
$3.49
Last traded 2023-12-19 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-111M
Net Income
+1.9% YoY
$-88M
Free Cash Flow
+35.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-45.3%
ROA-41.0%
ROIC-111469.9%
Valuation
P/E-4.4
P/B0.4
EV/EBITDA2.5
Leverage
Debt/Equity0.04
Current Ratio10.64
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z0.07
Beneish M0.00